Trade Pfizer ^PFE

BayBridge Capital Group LLC Decreases Position in Pfizer Inc. $PFE

Did a Hympavzi Trial Death and Tighter Guidance Just Reframe Pfizer's (PFE) Risk-Reward Story?

Pfizer (NYSE:PFE) Stock Price Down 1.3% - What's Next?

Option traders moderately bearish in Pfizer with shares down 1.25% | Markets Insider

Pfizer Stock Is Down -- Patient Death in Hemophilia Study Raises Safety Concerns

Patient Dies After Taking Pfizer's Drug for Blood Disorder

Welch Group LLC Boosts Stake in Pfizer Inc. $PFE

Adaptive Biotechnologies (ADPT): Valuation Check After New Pfizer T-Cell Discovery and AI Drug Collaboration Deals

Promising Dividend Stocks Worth Watching - December 23rd - Daily Political

Patient Dies In Pfizer's Long -term Extension Trial Of Hemophilia Drug

Trust Co. of Vermont Has $5.52 Million Stock Position in Pfizer Inc. $PFE - Stock Observer

Hemophilia trial death with Pfizer's Hympavzi under scrutiny | BioWorld

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial

Flagship Pioneering and Repertoire® Immune Medicines Announce Agreement to Identify T Cell-Targeted Immune Medicines for Prostate Cancer Under Strategic Partnership with Pfizer | Morningstar

Pfizer Inc. $PFE Shares Bought by Generali Investments CEE investicni spolecnost a.s. - Daily Political

Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma

Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial

Jim Cramer on Pfizer: "I'm Going to Say Just Weak Hold"

First Bank & Trust Buys 80,401 Shares of Pfizer Inc. $PFE

Adaptive Biotechnologies (ADPT) Is Up 10.1% After New Pfizer TCR-AI Collaboration Milestone Deal - What's Changed - Simply Wall St News

Wedge Capital Management L L P NC Has $26.91 Million Stock Position in Pfizer Inc. $PFE - Stock Observer

Pfizer Inc. $PFE Shares Bought by Viking Fund Management LLC - Daily Political

Pfizer and Cipla announce partnership - The Hindu

Patent cliffhanger: will China biotech throw Big Pharma a lifeline?

Voya Investment Management LLC Acquires 688,225 Shares of Pfizer Inc. $PFE - Daily Political

Pfizer (NYSE:PFE) Stock Acquired Rep. Gilbert Ray Cisneros, Jr. - Daily Political

Curated Wealth Partners LLC Decreases Stake in Pfizer Inc. $PFE - Stock Observer

Pfizer (NYSE:PFE) Shares Down 1.9% - Here's Why - Markets Daily

Drug companies line up to make deals with Trump after initial hesitation

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases

Axial Spondyloarthritis Market Size in the 7MM is anticipated to grow with a significant CAGR by 2034, estimates DelveInsight

New York State's 2025 Emerging Technology Advisory Board Releases Final Report to Boost Biotech Innovation, Commercialization and Public Health Impact | Morningstar

Pfizer (PFE) CEO's Struggling Because Of "a Good Hand," Says Jim Cramer

Jim Cramer Couldn't Stop Gushing About Johnson & Johnson (JNJ)'s Cancer Drugs

Wilsey Asset Management Inc. Purchases 118,248 Shares of Pfizer Inc. $PFE - Markets Daily

Will PADCEV-Keytruda Trial Success in Bladder Cancer Change Pfizer's (PFE) Pipeline-Driven Narrative? - Simply Wall St News

Pfizer and Cipla Join Forces: Exclusive Marketing Agreement for Key Medicines in India, ETPharma

Cipla ties up with Pfizer for exclusive marketing of four brands

Pfizer, Cipla Pact for 4 Brands in India

Pfizer, Cipla enter exclusive marketing agreement for select medicines in India

Addenda Capital Inc. Boosts Stock Position in Pfizer Inc. $PFE

Corex cough syrup gets Cipla boost as Pfizer strikes exclusive India deal

Pfizer Inc. (NYSE:PFE) Receives Average Recommendation of "Hold" from Analysts

Cipla, Pfizer ink partnership for exclusive marketing of four brands in India - The Economic Times

Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective

Medicare enrollees to pay 50% less for some drugs in 2025, report says - Yahoo News Canada

Company Website: https://www.pfizer.com NEW YORK -- (Busin

Pfizer Inc. $PFE Shares Sold by Thurston Springer Miller Herd & Titak Inc. - Markets Daily

Pfizer (NYSE:PFE) Has Affirmed Its Dividend Of $0.43

Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Pfizer Inc. (NYSE:PFE)

Fiduciary Alliance LLC Has $3.70 Million Position in Pfizer Inc. $PFE

Czech National Bank Purchases 54,306 Shares of Pfizer Inc. $PFE

Gradient Investments LLC Has $4.09 Million Stake in Pfizer Inc. $PFE

Lightning Round: I would buy M&T Bank tomorrow morning, says Jim Cramer

Pfizer (NYSE:PFE) Trading Down 1.9% - Time to Sell?

Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress

Best Dividend Stocks To Watch Today - December 17th - Stock Observer

Traws' Ratutrelvir Shows Activity In PAXLOVID-Ineligible COVID-19 Patients; Final Data Due In Jan.

Quintet Private Bank Europe S.A. Raises Position in Pfizer Inc. $PFE

PADCEV™ Plus Keytruda® Significantly Improves Survival for P

Medical Stocks To Research - December 17th - Daily Political

Pfizer Inc. $PFE Shares Acquired by Thrivent Financial for Lutherans - Markets Daily

Corient Private Wealth LLC Sells 179,789 Shares of Pfizer Inc. $PFE

Thrivent Financial for Lutherans Increases Stake in Pfizer Inc. $PFE - Stock Observer

Development of a cost-effectiveness analysis model for Duchenne muscular dystrophy utilizing the national registry in Japan

Enantioselective protein affinity selection mass spectrometry (E-ASMS)

FDA rejects plans to add black box warning for COVID-19 vaccines despite safety concerns - NaturalNews.com

Pfizer's Oncology and Obesity Pipelines Support a Narrow Moat Despite Looming Patent Expirations | Morningstar

Pfizer's stock drops after drug giant lowers its revenue forecast | Morningstar

Promising Dividend Stocks To Consider - December 16th - Markets Daily

Pfizer outlook, Humana leadership shake-up, Kraft Heinz's new CEO

Stock market today: Dow, S&P 500 slip as unemployment rate rises, Tesla marches toward record

Dow Jones Top Company Headlines at 3 PM ET: Pepsi Worked to Keep Prices Higher at Retailers to Protect Walmart, FTC Found | Pfizer ... | Morningstar

Top Pharmaceutical Stocks To Consider - December 16th

Dow Jones Top Company Headlines at 1 PM ET: Pepsi Worked to Keep Prices Higher at Retailers to Protect Walmart, FTC Found | Pfizer ... | Morningstar

Pfizer sees flat 2026 sales as it rebuilds drug pipeline

Stocks making the biggest moves midday: LUV, CRCL, HAL

Pfizer falls on disappointing guidance

Pfizer Reprices Lower as Investors Digest Slowing COVID Sales and LOE Impact | Investing.com AU

Pfizer Drops as Drugmaker Predicts Little Sales Growth in 2026

Pfizer's stock drops after it lowers its revenue forecast | Morningstar

US Stock Market Today: Wall Street mostly flat after jobs data signal softening labor market, Pfizer drops 3.3%

Dow Jones Top Company Headlines at 11 AM ET: Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings | Kraft ... | Morningstar

Pfizer 2026 guidance shows Metsera, Seagen deals will take time to pay off

Pfizer (NYSE:PFE) Stock Price Down 3.3% After Analyst Downgrade - Daily Political

Pfizer (NYSE:PFE) Updates FY 2026 Earnings Guidance

Pfizer (PFE) Stock: Why Shares Rose Despite Grim 2026 Profit Warning

Here's why Pfizer is revising its revenue forecasts | Morningstar

Pfizer forecasts 2026 profit below expectations

Pfizer: Can $108B Bet on Obesity Drugs Revive Its Struggling Stock? | Investing.com

Stocks making the biggest moves premarket: PFE, ROKU, KHC

Texas Permanent School Fund Corp Sells 213,755 Shares of Pfizer Inc. $PFE - Markets Daily

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision

Stock price forecast: 4 S&P 500 Stocks for 2025

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Week ahead: Apple earnings land as Fed seen holding rates

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk